Rifaximin Versus Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis in the Era of Antimicrobial Resistance: A Systematic Review and Meta-Analysis with Missing-Data Sensitivity Analyses.

Hu JH, Chang ML, Liu NJ, Sung KF, Hsieh YY, Chen CH

Open source

DOI
10.3390/biomedicines14102285
Published
2026 Oct 9
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14102285,
  title = {Rifaximin Versus Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis in the Era of Antimicrobial Resistance: A Systematic Review and Meta-Analysis with Missing-Data Sensitivity Analyses.},
  author = {Hu JH and Chang ML and Liu NJ and Sung KF and Hsieh YY and Chen CH},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14102285},
  url = {https://doi.org/10.3390/biomedicines14102285}
}

RIS

TY  - JOUR
TI  - Rifaximin Versus Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis in the Era of Antimicrobial Resistance: A Systematic Review and Meta-Analysis with Missing-Data Sensitivity Analyses.
AU  - Hu JH
AU  - Chang ML
AU  - Liu NJ
AU  - Sung KF
AU  - Hsieh YY
AU  - Chen CH
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14102285
UR  - https://doi.org/10.3390/biomedicines14102285
ER  - 

APA

JH, H., ML, C., NJ, L., KF, S., YY, H., & CH, C. (2026). Rifaximin Versus Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis in the Era of Antimicrobial Resistance: A Systematic Review and Meta-Analysis with Missing-Data Sensitivity Analyses.. Biomedicines. https://doi.org/10.3390/biomedicines14102285

Source records